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Signaling survival
 
Thymocytes must pass a series of
checkpoints on the road to becoming
mature T cells. On page 603, Mandal
et al. show that cells use Bcl2A1, a
member of the Bcl2 family of survival
proteins, to pass one critical check-
point. The cell cannot make substitutes
for this protein in a pinch, revealing
that Bcl2A1 may be uniquely special-
ized for promoting survival without
suppressing proliferation.
To become mature T cells, thy-
mocytes must express a functional T
cell receptor (TCR). A requisite early
step in fulfilling this goal is the expres-
sion of the pre-TCR—the 
 
 
 
 chain of
the mature TCR coupled with a pre–
 
 
 
Pollen polarize dendritic cells
 
How do pollen particles provoke allergic reactions? On page 
627, Traidl-Hoffmann et al. put some of the blame on 
bioactive lipids that are released from pollen and cause 
dendritic cells (DCs) to initiate a T helper 2 (Th2)-biased, 
allergy-promoting immune response. This response may 
explain in part why increased car fumes are associated with 
greater prevalence of allergies.
This group had discovered previously that pollen grains 
rapidly liberate eiconasoid-like substances, which are similar 
to prostaglandins and leukotrienes, when in an aqueous 
environment. These lipids bound to neutrophils and 
eosinophils (both involved in allergies and other immune 
reactions) and induced their activation, leading the group 
to propose that the release of these lipid mediators is an 
important event in allergic sensitization. What these data 
did not explain, however, was how the adaptive immune 
system becomes biased toward an allergy-inducing Th2 
response.
Traidl-Hoffmann et al. now show that soluble extracts 
from birch pollen and other common allergens inhibit the 
production of interleukin (IL)-12—the key cytokine involved 
in inhibiting Th2 responses—from activated DCs. These DCs 
could in turn bias naive T cells into becoming typical allergy-
promoting Th2 cells.
Biochemical analysis of these extracts allowed the authors 
to identify the culprit of the IL-12 inhibitory activity: a group 
of prostaglandin-like compounds called E1 phytoprostanes 
(PPE1). These results fit nicely with the known Th2-polarizing 
effect of human prostaglandin E2 (PGE2) on DCs. The signaling 
pathways are not identical, however, as PGE2, but not PPE1, 
also inhibits tumor necrosis factor (TNF) and IL-10.
The function of these lipids in the plant is not completely 
clear, but they may be triggered in response to stress, as pollen 
DCs (blue) exposed to pollen lipids polarize T cells (yellow) toward a 
Th2 phenotype.
 
exposed to air pollutants produce more of these compounds than 
do pollen from unpolluted areas. This may help explain why 
allergies are more prevalent in areas with high levels of car 
exhaust emissions. The authors are now looking for the receptor 
this compound uses to bind DCs. They also plan to assess whether 
DCs from allergy-prone individuals are more sensitive to the 
effects of PPE1 than those from nonallergic individuals.
 
chain—which sends essential survival
and proliferation signals to the devel-
oping cell. Activation of NF-
 
 
 
B was
shown recently to be required at this
checkpoint, known as 
 
 
 
-selection, but
beyond that the components of this sur-
vival signal have remained elusive.
In an attempt to define these
components, Mandal and colleagues
searched for NF-
 
 
 
B–responsive proteins
that may have a hand in 
 
 
 
-selection.
Their search led them to Bcl2A1, a pro-
tein involved in protecting B cells from
apoptosis.
When the authors looked for
Bcl2A1 in developing thymocytes, they
found that it was the sole member of
the Bcl2 family whose expression
was coordinated with 
 
 
 
-selection. In-
troduction of Bcl2A1 into thymocyte
progenitors lacking a pre-TCR, which
cannot undergo 
 
 
 
-selection, allowed
the cells to survive and differentiate in
vivo.
What remains mysterious is why the
cell doesn’t turn on one of the other
Bcl2 proteins, which are known to
have redundant functions, to make up
for the loss of Bcl2A1 in deficient cells.
The authors think this may be because
Bcl2 and Bcl-xL, although good at pro-
moting survival, inhibit proliferation—
an indispensable feature of pre-TCR
signaling.
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Phagocytosis without inﬂammation
 
The rare brain disorder Nasu-Hakola disease is a fatal 
neurodegenerative syndrome that has been linked to mutations in 
immune signaling proteins, but the mechanism had not been 
explored. In a study on page 647, Takahashi et al. connect this 
disease to defects in phagocytic cells that are 
required for removal of apoptotic cells and 
suppression of inflammation in the brain.
The link to disease involves the TREM2 
(triggering receptor expressed on myeloid cells-2) 
receptor and its associated adaptor protein 
DAP12, both known to be mutated in patients 
with Nasu-Hakola disease. TREMs are orphan 
receptors that associate with DAP12 to transmit 
signals in a variety of myeloid cells. The signals 
are primarily stimulatory: TREM1 signaling 
activates macrophages and neutrophils and can 
amplify Toll-like receptor signals, and TREM2 
activates immature dendritic cells. TREM2 is also 
expressed on microglial cells (phagocytic cells in 
the brain that remove apoptotic cells and debris 
from the brain), but its function on these cells 
had not been examined until now.
Phagocytosis of apoptotic neurons 
(red) by microglial cells (green)
requires TREM2.
 
Muscle cells under attack
 
Antitumor T cells may confuse regen-
erating muscle cells for their intended
targets and attack them, according to
new data from Casciola-Rosen et al.
(page 591). This unsolicited attack
may be the trigger for a self-perpetuating
autoimmune muscle disease.
Many proteins that are targeted in
tissue-specific autoimmune diseases are
expressed throughout the body. In most
cases, the mechanisms that preferentially
guide the autoreactive cells to the target
tissue  are not understood. An auto-
immune muscle disease known as der-
matomyositis is a good example. The
helicase protein Mi-2 has been associated
with dermatomyositis, but its expression
in muscle and its function in the pathol-
ogy of disease had never been explored.
Casciola-Rosen and colleagues now
show that muscle cells from patients
with dermatomyositis, but not those
from healthy controls, expressed high
levels of Mi-2 and other myositis auto-
antigens. In diseased muscle, autoantigens
had a distinct pattern of expression—
they were found only in immature re-
generating muscle cells. The expression Autoantigens associated with dermatomyositis are expressed in regenerating muscle cells (brown).
 
of the target antigen in regenerating
muscle cells of patients suggested to the
authors that it may be the effort of
the damaged muscle to repair itself, and
the resulting expression of the target
antigen, that perpetuates the disease.
But how does this destructive cycle
of muscle attack get activated in the first
place? The authors found one possible
explanation when they looked at tumors
that are frequently associated with der-
matomyositis. Similar to the situation in
diseased muscle cells, they found that
Mi-2  levels were elevated in tumor
tissues but not in normal tissues. They
suggest that an antitumor T cell response
is generated against Mi-2 and other
dermatomyositis-associated antigens.
In the unlucky event that a nonspecific
muscle injury occurs at the same time,
these tumor-specific T cells might
cross-react with newly growing mus-
cle cells and trigger the self-perpetu-
ating autoimmunity.
 
Intrigued by the connection between TREM2 and Nasu-Hakola 
disease, Takahashi and colleagues examined the function of this 
molecule on primary murine microglial cells. They found that TREM2 
ligation triggered phagocytosis of beads and apoptotic neurons in a 
process that required actin reorganization and 
the activation of the signaling molecule Erk. 
TREM2-stimulated phagocytosis did not coincide 
with activation of the cell or secretion of 
proinflammatory cytokines.
Impaired phagocytosis in the absence of 
TREM2 or functional DAP12 confirmed their 
role in phagocytosis. This experiment, however, 
also revealed a more striking finding. The loss 
of TREM2 provoked the microglial cells into 
producing inflammatory cytokines such as TNF 
and IL-1
 
 
 
, suggesting that TREM2 signals 
actively interfere with these pathways under 
normal circumstances. When TREM2 is missing, 
the lack of interference may explain the 
defective phagocytosis and aberrant activation 
of microglial cells that accompanies the 
buildup of cellular debris in the brain.
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